Subscription and demo access


 
About Interfax
Press Releases
Products & Services
Contact us
Customer Login
 


Headlines
 

05/26 22:16   Capitalization of Russian stock market decreases 0,72% on Friday
 
05/26 21:56   Number of civilian casualties of anti-ISIL coalition's strikes increases - Russian Foreign Ministry
 
05/26 21:46   Russian Finance Ministry expects court verdict on amount of interest on Ukraine's sovereign debt within next few weeks
 
05/26 21:43   Ukrainian Justice Minister hopes Karpiuk, Klykh to return home
 
05/26 21:41   Lawyer for businessman Katsyv hopes U.S. court decision on Prevezon Holdings will set example to other countries involved in 'Magnitsky case'
 
05/26 21:16   Almost three-fourths of Russians would like to bow to relics of Nicholas the Wonderworker brought to Moscow - poll
 
05/26 21:08   Moscow promises to respond appropriately to Russian diplomats' expulsion from Estonia (Part 2)
 
05/26 21:03   Court in London postpones interim verdict on Russia-Ukraine $3 bln sovereign debt dispute - Ukrainian Ministry of Finance
 
05/26 20:57   Court arrest 4 suspects of plotting terror attacks in Moscow until July 25
 
05/26 20:42   Moscow ought to respond in kind to Russian diplomats' expulsion from Estonia - Kosachyov
 


 

Interfax.com  |  Interfax news  |  Pharmstandard, Millhouse close deal to acquire...


News headlines


July 25, 2014 09:25

Pharmstandard, Millhouse close deal to acquire stakes in Biocad Holding

MOSCOW. July 25 (Interfax) - Pharmstandard (MOEX: PHST), a major Russian drug maker, and Millhouse have completed individual acquisitions of shares in Biocad Holding Ltd., the principal shareholder of St. Petersburg-based biotech company CJSC Biocad, the companies said in a joint statement.

Pharmstandard acquired a 20% stake in Biocad Holding Ltd., while a company affiliated with Millhouse acquired 50%.

Pharmstandard financed the acquisition with its own money, the press release states.

Biocad CEO and founder Dmitry Morozov will retain a 30% stake in Biocad Holding Ltd and will continue to run the company with his management team, the statement said.

Biocad develops, manufactures and promotes its own and generic drugs to treat illnesses in the areas of urology, gynecology, dermatovenereology, oncology and hematology, as well as autoimmune and infectious diseases. The company has a line of 14 drugs.

"Millhouse and Pharmstandard have a successful track record of working together to develop leaders in the pharmaceutical market. The companies previously cooperated on the acquisitions of ICN Pharmaceuticals, Inc. and CJSC Masterlek, and on Pharmstandard's initial public offering," the press release said.

It was reported earlier that in this deal the companies would buy the stake of Gazprombank (MOEX: GZPR), which acquired a controlling stake in the pharmaceutical company in 2011 for about $250 million-$300 million, as well as part of the stake held by company management.

RMG senior analyst Ksenia Arutyunova valued all of Biocad at $1 billion. Therefore, the stakes acquired by Pharmstandard and Millhouse are worth $200 million and $500 million respectively.

Millhouse is acting as a financial investor, who will divest the stake at some point, Arutyunova said, adding that this stake could be bought by Pharmstandard.

Biocad currently sells its products in Russia and other CIS countries. The company has offices in Ukraine, Belarus, Brazil, China, India and the United States. Biocad is also setting up production of drugs based on monoclonal antibodies in Brazil.

Biocad has two factories in Russia - in the Moscow Region and in the St. Petersburg special economic zone. The company had revenue of 3 billion rubles in 2013.

It was reported earlier that U.S. drug makers Pfizer and Amgen were interested in buying Biocad. The company was valued at $0.75 billion-$1 billion.

Vp of

(Our editorial staff can be reached at eng.editors@interfax.ru)

/Interfax/
 Subscription
You can access a demo version of, receive more information about or subscribe to Interfax publications by filling in and returning the form below. We also have dozens of reports in the Russian language, please indicate if you are interested.
Title:


Phone:


E-mail:


First name:


Company:


Country:
Last name:


Division:


City:
Products:
Central Asia & Caucasus Business Weekly
Central Asia General Newswire
Global Gas Analytics
Global Natural Gas Daily
Interfax Via Bloomberg Terminal
Kazakhstan General Newswire
Kazakhstan Mining Weekly
Kazakhstan Oil & Gas Weekly
Russia & CIS Announcements
Russia & CIS Banking and Finance Weekly
Russia & CIS Business and Financial Daily
Russia & CIS Business and Financial Newswire
Russia & CIS Business and Investment Weekly
Russia & CIS Business Law Weekly
Russia & CIS Business news
Russia & CIS Defense Industry Weekly
Russia & CIS Diplomatic Panorama
Russia & CIS Energy Daily
Russia & CIS Energy Newswire
Russia & CIS Events Calendar
Russia & CIS Food and Agriculture Weekly
Russia & CIS General Newswire
Russia & CIS Headline News
Russia & CIS Insurance Weekly
Russia & CIS IT and Telecom Weekly
Russia & CIS Metals and Mining Weekly
Russia & CIS Military Daily
Russia & CIS Military Newswire
Russia & CIS Military Weekly
Russia & CIS Oil and Gas Weekly
Russia & CIS Presidential Bulletin
Russia & CIS Statistics Weekly
Russia Health & Pharmaceuticals
Russia Market Roundup
Russia Press Review
Ukraine Business Daily
Ukraine Business Weekly
Ukraine General Newswire
Please enter the digits from picture in the box below:

May 26, 2017
 
22:16
Capitalization of Russian stock market decreases 0,72% on Friday
 
21:56
Number of civilian casualties of anti-ISIL coalition's strikes increases - Russian Foreign Ministry
 
21:46
Russian Finance Ministry expects court verdict on amount of interest on Ukraine's sovereign debt within next few weeks
 
21:43
Ukrainian Justice Minister hopes Karpiuk, Klykh to return home
 
21:41
Lawyer for businessman Katsyv hopes U.S. court decision on Prevezon Holdings will set example to other countries involved in 'Magnitsky case'
 
21:16
Almost three-fourths of Russians would like to bow to relics of Nicholas the Wonderworker brought to Moscow - poll
 
21:08
Moscow promises to respond appropriately to Russian diplomats' expulsion from Estonia (Part 2)
 
21:03
Court in London postpones interim verdict on Russia-Ukraine $3 bln sovereign debt dispute - Ukrainian Ministry of Finance
 
20:57
 
20:42
Moscow ought to respond in kind to Russian diplomats' expulsion from Estonia - Kosachyov
 
20:26
Sergei Valchenko wins Interfax award named after Vitaly Dzhibuti
 
20:19
Capitalization of Russian stock market decreases 0,72% on Friday
 
20:16
Russian Interior Ministry's computer system switched off at time of cyber attack to prevent virus infiltration - deputy minister
 
20:14
Ruble rises against dollar, euro as oil stabilizes
 
 more headlines 



Interviews
 

.
Pakistani Defense Minister Khawaja Muhammad Asif has given an interview to Interfax correspondent Veronika Vishnyakova in which he speaks about his recent talks with Russian Defense Minister Sergei Shoigu, Pakistan-Russian interaction on Afghanistan, as well as his expectations from upcoming entry of Pakistan to the Shanghai Cooperation Organization (SCO).

more
.
.
Austrian Ambassador to Russia Emil Brix has given an interview to Interfax foreign political desk chief Olga Golovanova on the occasion of the 500th anniversary of bilateral relations, in which he speaks about Austrias position on Ukraine in light of resolving the South Tyrol conflict, about the use of sanctions in international relations, which he considers unwise, about Austrias neutral status, as well as Austrian-Russian energy cooperation.

more
.
.
High Representative of the European Union for Foreign Affairs and Security Policy / Vice-President of the European Commission Federica Mogherini has given an interview to Interfax correspondents Alexander Korzun and Viktor Onuchko ahead of her first visit to Russia. The interview covers such issues as prospects of partnership between the European Union and Russia, the situation in Ukraine, anti-Russian sanctions and the Syrian conflict.

more

 
  
 ©   1991—2017   Interfax Information Service. All rights reserved.
contact information   |   Interfax offices   |   made by web.finmarket

News and other data on this site are provided for information purposes only, and are not intended for republication or redistribution. Republication or redistribution of Interfax content, including by framing or similar means, is expressly prohibited without the prior written consent of Interfax.

Browse other Interfax sites:  Interfax.ru   |   IFX.RU   |   Interfax Group   Rambler's Top100